|
In Focus
Stenosis in Grafts & Native Fistulas
Since venous pressures can only detect
resistance in the venous outflow tract, they cannot detect most stenoses in fore arm fistulas and 40% of stenoses in upper arm fistulas.
The Transonic Hemodialysis Monitoring system is the only system that can detect
hemodynamically significant stenoses at all sites (arterial inflow, between the dialysis needles, venous outflow) in both grafts and fistulas.
Dollars and Cents
Vascular Access Monitoring Saves Institutions and Insurers Money
A study by Vanderbilt University and Renal Care Group in Nashville reports "total vascular access related costs were reduced by 48.5% for Vascular Access Blood Flow Monitoring (VABFM) vs.
non-monitoring".2 These costs include a reduction in related costs of 78% for hospitalizations, 82% for catheter placements and 90% for thrombectomies.
- The case for Medical Reimbursement
- Letter including the reimbursement code to Insurance Provider’s
- Cost Savings Worksheet Resulting from Hemodialysis Access Flow Surveillance
Transonic Flow-QC® in Recent Publications
SMART stent for treating angioplasty-resistant hemodialysis access venous stenoses
The
purpose of this study was to evaluate the SMART stent for treating angioplasty-resistant hemodialysis access venous stenoses. The SMART stent was found to have a 98% technical success rate and a
97% clinical success rate. The smart stent is safe and effective for treating dialysis access venous stenoses that are resistant to standard agioplasty.
FAQ
What is Glomerular Filtration Rate (GFR), and how does it correlate to the kidney’s ability
to filter blood?
Glomerular filtration is the process by which the kidneys filter the blood, removing excess wastes and
fluids. Glomerular filtration rate (GFR) is used to determine how well the blood is filtered by the kidneys. It is one way to measure remaining kidney function and it is the best test to measure the
level of kidney function and to determine the stage of kidney disease.
See how..>
|
